Overall Fundamental outlook

|fundrankingplaceholder|
|techrankingplaceholder|

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for GRANULES
Revenue projections for GRANULES

GRANULES is projected to see a decline in revenue compared to last year, which could lead to investor caution. A drop in earnings is often viewed as a negative signal for profitability, making it more difficult for the company to maintain investor confidence in its financial health.

Financial Ratios:

currentRatio 1.801000
forwardPE 19.422337
debtToEquity 29.735000
earningsGrowth 0.313000
revenueGrowth 0.228000
grossMargins 0.650420
operatingMargins 0.183840
trailingEps 24.500000
forwardEps 38.950000

With a current ratio 1.801, GRANULES demonstrates the ability to service its short-term debt without difficulty. The company's strong cash reserves and current assets ensure that it can meet its liabilities, reflecting financial stability and healthy liquidity.
GRANULES's Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.
Granules India Limited's low Debt-to-Equity ratio indicates that the company isn't heavily dependent on debt financing. This lower leverage reduces financial risk and enhances stability, showing that Granules India Limited is well-positioned to manage its obligations without the burden of excessive debt.
With earnings and revenue growth in positive territory, GRANULES is projected to expand its business. This strong financial performance suggests the company will continue to grow, as increased profitability and sales drive future success.
Granules India Limited's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that Granules India Limited is likely to outperform its previous year's financial performance.

Price projections:

Price projections for GRANULES
Price projections for GRANULES

The price of GRANULES has repeatedly been close to the lower limit of price projections. This trend suggests that the stock may be underperforming, raising concerns among investors about future performance.

Recommendation changes over time:

Recommendations trend for GRANULES
Recommendations trend for GRANULES


GRANULES has been receiving a buy bias from analysts, indicating confidence in its investment potential. This could drive more investors to view GRANULES as a reliable choice for their money, offering a promising avenue for future growth and financial gains.